ADMA Biologics Inc vs Burlington Stores Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Burlington Stores Inc trades at $359.51 (market cap $22.59B). The key difference: Burlington Stores Inc is far larger — about 10.2× ADMA Biologics Inc's market cap, and Burlington Stores Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | BURL | |
|---|---|---|
Market Cap | $2.22B | $22.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $372.19 |
52-Week Low | $7.60 | $242.43 |
Enterprise Value | $2.29B | $27.71B |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Burlington is a leading off-price retailer in the US, offering branded apparel, footwear, and home goods at significant discounts. It operates hundreds of stores focused on delivering high-quality products at great value.
Read more on BURL →